<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar407.anc" start="26390" end="26401" sStart="-1" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" annotator="tofox" text="Equal amounts of each sample were loaded and run on a 10% SDS-PAGE gel and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membranes using a semi-dry transblotting apparatus (Bio-Rad, Richmond, CA, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="4469" end="4475" sStart="null" offset="117" sid="r9.normal.j.0205" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Ang-1 staining on macrophages was also significantly higher in RA (39%) compared to OA (10%) and normal cells (0%) ( P &lt; 0.05)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="5932" end="5938" sStart="null" offset="156" sid="r9.normal.j.0935" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="The Ang-2 mRNA expression in RA synovial tissue was similar to that from OA patients, and both were significantly higher than normal." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="17238" end="17244" sStart="null" offset="112" sid="r9.normal.j.0903" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Hypothetically, in RA synovial tissue the dominating Ang-1 induces the Tie2 pathway, whereas in normal synovial tissue higher Ang-2 presence blocks Ang-1 binding to Tie2 and inhibits its autophosphorylation." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="7414" end="7420" sStart="null" offset="129" sid="r9.normal.j.0751" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Tie1 mRNA expression was significantly higher in RA synovial tissue compared to OA synovial tissue (3-fold), normal synovial tissue (9." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="15678" end="15684" sStart="null" offset="255" sid="r9.normal.j.0459" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Using the Santa Cruz Biotechnology antibody we showed that Tie2 expression was significantly upregulated both in RA and OA synovial tissue lining cells, macrophages, endothelial cells and vascular smooth muscle compared to normal synovial tissue." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="12059" end="12065" sStart="null" offset="287" sid="r9.normal.j.0263" wn="4" wnkey="normal%5:00:00:perpendicular:00" annotator="cgozo" text="In agreement with our finding, it has been reported that primary cultured macrophages and precursor macrophage cell lines mainly express Ang-2 mRNA [ 23 ] . In contrast to Ang-1, Ang-2 was distributed in a similar pattern in RA and OA compared to normal synovial tissues (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="8867" end="8873" sStart="null" offset="9" sid="r9.normal.j.0127" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="9-fold), normal synovial tissue (4-fold) and RA synovial tissue fibroblasts (9." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="7036" end="7042" sStart="null" offset="208" sid="r9.normal.j.0732" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Additionally, all disease groups demonstrated minimal percentages of Tie1 cell staining on synovial tissue lymphocytes (RA 1%, OA 2%, normal 6%) and fibroblasts (RA 18%, OA 18%, normal 30%)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="8063" end="8069" sStart="null" offset="123" sid="r9.normal.j.0652" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Endothelial cells showed relatively high Tie2 positive staining in all disease groups (RA 71%, OA 66%, normal 49%)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="7842" end="7848" sStart="null" offset="207" sid="r9.normal.j.0938" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Tie2 was significantly upregulated in RA and OA synovial tissue lining cells (RA 71%, OA 68%), macrophages (RA 71%, OA 72%) and smooth muscle cells (RA 71%, OA 66%) compared to normal synovial tissue ( P &lt; 0.05) using the Santa Cruz antibodies (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="4782" end="4788" sStart="null" offset="108" sid="r9.normal.j.0930" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="The inflammatory and vascularity scores were higher in RA synovial tissue in comparison to OA and normal." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="9647" end="9653" sStart="null" offset="169" sid="r9.normal.j.0818" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Ang-1 was more highly expressed in synovial tissue from RA patients than in either OA or normal synovial tissues; expression in OA tissue was similar to normal." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="6091" end="6097" sStart="null" offset="151" sid="r9.normal.j.0370" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Interestingly, in RA synovial tissue fibroblasts, Ang-2 mRNA was expressed at low levels compared to that found in whole RA, OA or normal synovial tissue (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/ar407.anc" start="6032" end="6038" sStart="null" offset="92" sid="r9.level.n.0679" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="Interestingly, in RA synovial tissue fibroblasts, Ang-2 mRNA was expressed at low levels compared to that found in whole RA, OA or normal synovial tissue (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar407.anc" start="22621" end="22627" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="For each PCR run, a master mixture was prepared on ice with 1? Platinum PCR buffer (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA), 1.5 mM MgCl 2 , 0.2 mM of each deoxynucleoside triphosphate, 0.2 ?M each primer, 2.5 units platinum Taq DNA polymerase (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar407.anc" start="22411" end="22417" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="For each PCR run, a master mixture was prepared on ice with 1? Platinum PCR buffer (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA), 1.5 mM MgCl 2 , 0.2 mM of each deoxynucleoside triphosphate, 0.2 ?M each primer, 2.5 units platinum Taq DNA polymerase (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar407.anc" start="24945" end="24951" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" annotator="veweser" text="Briefly, 3 ?l of the cDNA was in a reaction of 25 ?l that contained final concentrations of 1? Platinum PCR buffer (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA), 3.5 mM MgCl 2 , 200 ?M dNTP, 500 nM each primer (Mega Bases, Chicago, IL, USA), 200 nM FAM-TAMRA probe (Mega Bases, IL, USA), 100 nM Blue 636 (BD 636), 0.05 units platinum Taq DNA polymerase (Gibco/Life Technologies, Grand &lt;b&gt;Island&lt;/b&gt;, NY, USA)." />
  </sentences>
</list>